IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Metabolic Brain Disease

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

3.63

h-Index

2023-2024

 78

Rank

2023-2024

 5880

SJR

2023-2024

 0.831

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Metabolic Brain Disease
Abbreviation Metab. Brain Dis.
Publication Type Journal
Subject Area, Categories, Scope Biochemistry (Q2); Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3)
h-index 78
Overall Rank/Ranking 5880
SCImago Journal Rank (SJR) 0.831
Impact Score 3.63
Publisher Springer New York
Country United States
ISSN 15737365, 08857490
Best Quartile Q2
Coverage History 1986-2023




About Metabolic Brain Disease


Metabolic Brain Disease is a journal covering the technologies/fields/categories related to Biochemistry (Q2); Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3). It is published by Springer New York. The overall rank of Metabolic Brain Disease is 5880. According to SCImago Journal Rank (SJR), this journal is ranked 0.831. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 78. The best quartile for this journal is Q2.

The ISSN of Metabolic Brain Disease journal is 15737365, 08857490. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Metabolic Brain Disease is cited by a total of 2077 articles during the last 3 years (Preceding 2023).


Metabolic Brain Disease Impact IF 2023-2024


The Impact IF 2023 of Metabolic Brain Disease is 3.63, which is computed in 2024 as per its definition. Metabolic Brain Disease IF is increased by a factor of 0.1 and approximate percentage change is 2.83% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Metabolic Brain Disease Impact IF 2024 Prediction


Impact IF 2023 of Metabolic Brain Disease is 3.63. If the same upward trend persists, Impact IF may rise in 2024 as well.


Impact IF Trend


Year wise Impact IF of Metabolic Brain Disease. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 3.63
2022 3.53
2021 3.64
2020 3.19
2019 2.79
2018 2.46
2017 2.49
2016 2.35
2015 2.79
2014 3.00

Metabolic Brain Disease h-index


  Table Setting

Metabolic Brain Disease has an h-index of 78. It means 78 articles of this journal have more than 78 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Metabolic Brain Disease ISSN


The ISSN of Metabolic Brain Disease is 15737365, 08857490. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Metabolic Brain Disease Rank and SCImago Journal Rank (SJR)


The overall rank of Metabolic Brain Disease is 5880. According to SCImago Journal Rank (SJR), this journal is ranked 0.831. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Metabolic Brain Disease by Year


Year SJR
2023/2024 Coming Soon
2023 0.831
2022 0.761
2021 0.729
2020 0.851
2019 0.775
2018 0.795
2017 0.909
2016 0.900
2015 0.991
2014 1.112

Ranking of Metabolic Brain Disease by Year


Year Ranking
2023/2024 Coming Soon
2023 5880
2022 6398
2021 6507
2020 5544
2019 6166
2018 5938
2017 4985
2016 5062
2015 4513
2014 3712

Metabolic Brain Disease Publisher


Table Setting

Metabolic Brain Disease is published by Springer New York. It's publishing house is located in United States. Coverage history of this journal is as following: 1986-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Metabolic Brain Disease is Metab. Brain Dis.. This abbreviation ('Metab. Brain Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Metabolic Brain Disease


If your research field is/are related to Biochemistry (Q2); Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Metabolic Brain Disease?

Metabolic Brain Disease latest impact IF is 3.63. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.64 (2021) and 2.35 (2016), respectively, in the last 10 years. Moreover, its average IS is 2.99 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Metabolic Brain Disease?

The Metabolic Brain Disease has an SJR (SCImago Journal Rank) of 0.831, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.112 in 2014 and the lowest being 0.729 in 2021. Furthermore, the average SJR of the Metabolic Brain Disease over the previous 10-year period stands at 2.99.


What's the latest h-index of the Metabolic Brain Disease?

The latest h-index of the Metabolic Brain Disease is 78.


Who's the publisher of the Metabolic Brain Disease?

The Metabolic Brain Disease is published by the Springer New York, with its country of publication being the United States.


What's the current ranking of the Metabolic Brain Disease?

The Metabolic Brain Disease is currently ranked 5880 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 3712 in 2014 and its lowest position of 6507 in 2021.


What's the abbreviation or short name for the Metabolic Brain Disease?

The standard ISO4 abbreviation for the Metabolic Brain Disease is Metab. Brain Dis..


Is the "Metabolic Brain Disease" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Metabolic Brain Disease is classified as a journal that the Springer New York publishes.


What's the scope or major areas of the Metabolic Brain Disease?

The Metabolic Brain Disease encompasses the following areas:

  • Biochemistry
  • Neurology (clinical)
  • Cellular and Molecular Neuroscience

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Metabolic Brain Disease?

The Metabolic Brain Disease is assigned the following International Standard Serial Numbers (ISSN): 15737365, 08857490.


What's the best quartile of the Metabolic Brain Disease?

The best quartile for the Metabolic Brain Disease is Q2 (2023).


What's the coverage history of the Metabolic Brain Disease?

The Metabolic Brain Disease coverage history can be summarized as follows: 1986-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
Business Strategy Review journal 31512 Wiley-Blackwell Publishing Ltd 33 0.04
Child and Family Social Work journal 8089 Wiley-Blackwell Publishing Ltd 75 2.10
Socialism and Democracy journal 25103 Taylor and Francis Ltd. 18 0.12
Archives of the Balkan Medical Union journal 23592 Balkan Medical Union 12 0.21
Built Environment journal 12809 Alexandrine Press 46 1.18
Biological Procedures Online journal 4092 BioMed Central Ltd 48 3.54
European Journal of Cancer, Supplement journal 6710 Elsevier Ltd 29 0.33
European Journal of Wildlife Research journal 9693 Springer Verlag 59 1.76

Check complete list




Year wise Impact Score (IS) of Metabolic Brain Disease

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 3.63
2022 3.53
2021 3.64
2020 3.19
2019 2.79
2018 2.46
2017 2.49
2016 2.35
2015 2.79
2014 3.00



Top Journals/Conferences in Biochemistry

Cell
Elsevier B.V. | United States

Nature Medicine
Nature Research | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Nature Methods
Nature Publishing Group | United Kingdom

Nature Catalysis
Nature Publishing Group | United States

Nature Reviews Methods Primers
Springer Nature | United States

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Cell Genomics
Cell Press | United States

Nature Protocols
Nature Publishing Group | United Kingdom

Chem
Elsevier Inc. | United States

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

JAMA Neurology
American Medical Association | United States

Molecular Neurodegeneration
BioMed Central Ltd | United Kingdom

Acta Neuropathologica
Springer Science and Business Media Deutschland GmbH | Germany

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Sleep Medicine Reviews
W.B. Saunders Ltd | United Kingdom

Translational Neurodegeneration
BioMed Central Ltd | United Kingdom

See All

Top Journals/Conferences in Cellular and Molecular Neuroscience

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd | United Kingdom

Acta Neuropathologica
Springer Science and Business Media Deutschland GmbH | Germany

Molecular Psychiatry
Springer Nature | United Kingdom

Translational Neurodegeneration
BioMed Central Ltd | United Kingdom

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neuroinflammation
BioMed Central Ltd | United Kingdom

Acta neuropathologica communications
BioMed Central Ltd | United Kingdom

GLIA
John Wiley & Sons Inc. | United States

Cell Death and Disease
Nature Publishing Group | United Kingdom

See All